Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operational Highlights
RVTY logo

Revvity's Q3 Revenue Rises 2% to $699M Amid Tariff Pressures

RVTY10-QFiling Date: 11/4/2025
Revvity, Inc.
Description

What this story covers

Revvity Inc. reported Q3 revenue up 2% to $699M, driven by diagnostics growth and software gains, but margins compressed from $25M tariff costs. Year-to-date income fell to $144M. Strong liquidity at $931M cash supports buybacks and dividends, with hedges managing forex risks amid global challenges.

Story snapshot

CompanyRevvity, Inc.
TickerRVTY
VariantStandard detailed
Duration10:28
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0000031791-25-000037

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in